| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GOVX
GeoVax Labs
|
May 26, 2026 | BUY |
Strong Buy
+6467.8% avg upside
5 analysts
|
$10.00
747.44% Upside
|
-52.7% |
|
PTHS
Pelthos Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+109.2% avg upside
8 analysts
|
$55.00
103.58% Upside
|
-3.4% |
|
BFRI
Biofrontera
|
May 15, 2026 | BUY |
Strong Buy
+511.5% avg upside
2 analysts
|
$9.00
817.33% Upside
|
-0.6% |
|
CLNN
Clene
|
May 14, 2026 | BUY |
Strong Buy
+448.2% avg upside
11 analysts
|
$30.00
405.99% Upside
|
-3.0% |
|
APVO
Aptevo Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
+157.8% avg upside
4 analysts
|
$21.00
337.52% Upside
|
-0.3% |
|
REVB
Revelation Biosciences
|
May 08, 2026 | BUY |
Strong Buy
+1395.3% avg upside
1 analyst
|
$16.00
1395.31% Upside
|
· |
|
MDCX
Medicus Pharma Ltd
|
May 07, 2026 | BUY |
Strong Buy
+3801.0% avg upside
4 analysts
|
$9.00
2458.95% Upside
|
-2.5% |
|
CLRB
Cellectar Biosciences
|
May 05, 2026 | BUY |
Strong Buy
+3333.9% avg upside
7 analysts
|
$11.00
343.63% Upside
|
-1.3% |
|
CELZ
Creative Medical Technology Holdings
|
Apr 28, 2026 | BUY |
Strong Buy
+792.9% avg upside
1 analyst
|
$20.00
792.91% Upside
|
· |
|
BRTX
BioRestorative Therapies
|
Apr 02, 2026 | BUY |
Strong Buy
+1886.1% avg upside
3 analysts
|
$15.00
3654.69% Upside
|
-27.5% |
|
GTBP
GT Biopharma
|
Mar 02, 2026 | BUY |
Strong Buy
+2080.2% avg upside
3 analysts
|
$3.00
553.53% Upside
|
-8.8% |
|
MBRX
Moleculin Biotech
|
Feb 23, 2026 | BUY |
Strong Buy
+612.5% avg upside
5 analysts
|
$31.00
1007.14% Upside
|
+0.9% |
|
ZVRA
Zevra Therapeutics
|
Jul 22, 2025 | BUY |
Strong Buy
+88.3% avg upside
15 analysts
|
$21.00
66.63% Upside
|
+8.9% |
|
OTRKQ
Ontrak
|
Jul 08, 2025 | BUY |
Buy
+21716566.7% avg upside
7 analysts
|
$3.00
2999900.04% Upside
|
· |
|
BPTH
Bio-Path Holdings
|
Jun 04, 2025 | BUY |
Strong Buy
+22655.3% avg upside
6 analysts
|
$2.00
5455.50% Upside
|
· |
|
TENX
Tenax Therapeutics
|
May 15, 2025 | BUY |
Strong Buy
+217.0% avg upside
8 analysts
|
$30.00
152.72% Upside
|
+110.2% |
|
NUWE
Nuwellis
|
May 13, 2025 | BUY |
Strong Buy
+16398.4% avg upside
7 analysts
|
$11.00
7871.03% Upside
|
-97.5% |
|
ES:ORY
Oryzon Genomics SA
|
May 12, 2025 | BUY |
Strong Buy
+226.7% avg upside
2 analysts
|
$12.00
279.98% Upside
|
· |
|
NVCT
Nuvectis Pharma
|
Oct 28, 2024 | BUY |
Strong Buy
+42.9% avg upside
6 analysts
|
$20.00
58.83% Upside
|
-18.0% |
|
BGMS
Bio Green Med Solution
|
Oct 23, 2024 | HOLD |
Strong Buy
+1532.5% avg upside
7 analysts
|
— | -98.4% |
|
AU:IMU
Imugene
|
Sep 03, 2024 | BUY |
Strong Buy
+572.6% avg upside
2 analysts
|
$0.59
500.33% Upside
|
· |
|
GRDX
GridAI Technologies
|
May 21, 2024 | BUY |
Strong Buy
+294.2% avg upside
7 analysts
|
$36.00
627.25% Upside
|
-86.2% |
|
DFTX
Definium Therapeutics
|
Mar 07, 2024 | BUY |
Strong Buy
+46.3% avg upside
20 analysts
|
$36.00
47.32% Upside
|
-24.1% |
|
HSDT
Solana Company
|
Mar 05, 2024 | BUY |
Strong Buy
+1293.7% avg upside
8 analysts
|
$24.00
1399.92% Upside
|
-91.7% |
|
PBLA
Panbela Therapeutics
|
Dec 18, 2023 | BUY |
Buy
+4504404.4% avg upside
3 analysts
|
$500.00
4504404.43% Upside
|
· |
|
IMMX
Immix Biopharma
|
Feb 27, 2023 | BUY |
Strong Buy
+79.1% avg upside
7 analysts
|
$14.00
53.30% Upside
|
+52.3% |
|
OCGN
Ocugen
|
Jun 15, 2022 | BUY |
Strong Buy
+643.8% avg upside
17 analysts
|
$8.00
550.39% Upside
|
-74.2% |
|
AMPE
Ampio Pharmaceuticals
|
Apr 28, 2022 | BUY |
Buy
+9184.6% avg upside
4 analysts
|
$30.00
16284.55% Upside
|
-92.6% |
|
BNBX
BNB Plus
|
Oct 25, 2021 | BUY |
Strong Buy
+1840.7% avg upside
5 analysts
|
$24.00
4802.95% Upside
|
-70.6% |
|
SEELQ
Seelos Therapeutics
|
Sep 27, 2021 | BUY |
Buy
+46385614.3% avg upside
10 analysts
|
$8.00
7999899.94% Upside
|
-56.1% |
|
NTBLQ
Notable Labs
|
Aug 30, 2021 | BUY |
Buy
+809999900.0% avg upside
12 analysts
|
$7.00
699999900.03% Upside
|
· |
|
NOVN
Novan
|
Jun 11, 2021 | BUY |
Buy
6 analysts
|
$40.00
|
· |
|
SHLS
Shoals Technologies Group
|
Mar 11, 2021 | BUY |
Strong Buy
+48.1% avg upside
26 analysts
|
$38.00
302.61% Upside
|
-48.2% |
|
ARDS
Aridis Pharmaceuticals
|
Nov 22, 2020 | BUY |
Strong Buy
+427319.4% avg upside
5 analysts
|
$18.00
580545.11% Upside
|
-66.4% |
|
INO
Inovio Pharmaceuticals
|
Nov 17, 2020 | SELL |
Buy
+815.5% avg upside
19 analysts
|
$8.00
620.72% Upside
|
+36.8% |
|
HYPD
Hyperion DeFi
|
Oct 14, 2020 | BUY |
Strong Buy
+137.7% avg upside
8 analysts
|
$11.00
211.63% Upside
|
· |
|
INMB
Inmune Bio
|
Jul 14, 2020 | BUY |
Buy
+834.0% avg upside
11 analysts
|
$26.00
1900.06% Upside
|
+45.8% |
|
ONCY
Oncolytics Biotech
|
Apr 20, 2020 | BUY |
Strong Buy
+670.7% avg upside
12 analysts
|
$9.00
865.86% Upside
|
+115.7% |
|
TRVN
Trevena
|
Sep 15, 2016 | BUY |
Buy
+128278.4% avg upside
11 analysts
|
$14.00
126026.10% Upside
|
· |
|
PALI
Palisade Bio
|
Sep 13, 2016 | BUY |
Strong Buy
+1425.2% avg upside
15 analysts
|
$4.00
127.23% Upside
|
-67.6% |
|
HRTX
Heron Therapeutics
|
Sep 09, 2016 | BUY |
Strong Buy
+6864.0% avg upside
21 analysts
|
$55.00
14100.96% Upside
|
-14.9% |
|
AXSM
Axsome Therapeutics
|
Aug 19, 2016 | BUY |
Strong Buy
-10.5% avg upside
28 analysts
|
$29.00
88.49% Downside
|
-33.7% |
|
INCY
Incyte
|
Aug 10, 2016 | BUY |
Buy
+1.0% avg upside
47 analysts
|
$92.00
7.01% Downside
|
+46.3% |
|
CTSO
Cytosorbents
|
Aug 10, 2016 | BUY |
Strong Buy
+2452.9% avg upside
13 analysts
|
$24.00
4931.37% Upside
|
-4.9% |
|
TGTX
TG Therapeutics
|
Aug 09, 2016 | BUY |
Strong Buy
-32.7% avg upside
19 analysts
|
$28.00
45.68% Downside
|
· |
|
SCYX
SCYNEXIS
|
Aug 09, 2016 | BUY |
Strong Buy
+233.1% avg upside
10 analysts
|
$16.00
321.04% Upside
|
-20.1% |
|
AKBA
Akebia Therapeutics
|
Aug 09, 2016 | BUY |
Strong Buy
+864.1% avg upside
16 analysts
|
$26.00
2449.06% Upside
|
+74.4% |
|
CLDX
Celldex
|
Aug 09, 2016 | BUY |
Strong Buy
+18.8% avg upside
28 analysts
|
$16.00
51.38% Downside
|
-45.9% |
|
RMTI
Rockwell Med
|
Aug 09, 2016 | SELL |
Buy
+1422.7% avg upside
11 analysts
|
$3.00
361.21% Upside
|
+6.2% |
|
PCRX
Pacira Pharmaceuticals
|
Aug 05, 2016 | HOLD |
Buy
+72.5% avg upside
21 analysts
|
— | -14.5% |
|
NKTR
Nektar Therapeutics
|
Aug 04, 2016 | BUY |
Buy
+18.4% avg upside
25 analysts
|
$18.00
70.55% Downside
|
+14.7% |
|
IPCIQ
IntelliPharmaCeutics International
|
Jul 06, 2016 | BUY |
Buy
+1649999899.9% avg upside
4 analysts
|
$8.00
799999899.92% Upside
|
· |
|
REGN
Regeneron
|
Mar 08, 2016 | BUY |
Strong Buy
+27.5% avg upside
57 analysts
|
$489.00
19.54% Downside
|
-3.4% |
|
SNGX
Soligenix
|
Nov 12, 2015 | BUY |
Buy
+720.9% avg upside
6 analysts
|
$5.00
1143.75% Upside
|
-60.7% |
|
LITS
Lite Strategy
|
Dec 08, 2014 | BUY |
Buy
+1102.6% avg upside
13 analysts
|
$16.00
1640.67% Upside
|
· |
|
BMRN
BioMarin Pharmaceutical
|
Oct 24, 2014 | HOLD |
Strong Buy
+71.7% avg upside
52 analysts
|
— | +28.5% |
|
UTHR
United Therapeutics
|
Feb 26, 2013 | HOLD |
Buy
-20.4% avg upside
26 analysts
|
— | +72.2% |
|
IMNN
Imunon
|
Jan 17, 2013 | SELL |
Strong Buy
+689.6% avg upside
11 analysts
|
$1.00
46.29% Downside
|
+88.0% |
|
ASMB
Assembly Biosciences
|
Jun 29, 2012 | BUY |
Strong Buy
+39.2% avg upside
10 analysts
|
— | -43.8% |
|
HALO
Halozyme
|
Apr 16, 2012 | BUY |
Strong Buy
-13.1% avg upside
20 analysts
|
$11.00
84.04% Downside
|
-32.9% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.